THOMAS EARL STARZL
Medical Practice in Pittsburgh, PA

License number
Pennsylvania MD024669E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Pittsburgh, PA 15213

Personal information

See more information about THOMAS EARL STARZL at radaris.com
Name
Address
Phone
Thomas Starzl, age 98
4320 Centre Ave, Pittsburgh, PA 15213
(412) 480-8685
Thomas Starzl
Pittsburgh, PA
(412) 681-0780
Thomas E Starzl
3459 5Th St, Pittsburgh, PA 15213
(412) 624-0112
Thomas E Starzl
3601 5Th Ave, Pittsburgh, PA 15213
(412) 624-0112
Thomas E Starzl
3601 5Th St, Pittsburgh, PA 15213
(412) 624-0112

Organization information

See more information about THOMAS EARL STARZL at bizstanding.com

Sleep Medicine Center - Thomas Earl Starzl MD

3459 5 Ave #S639-11, Pittsburgh, PA 15213

Categories:
Physicians & Surgeons
Phone:
(412) 647-2345 (Phone)

Professional information

See more information about THOMAS EARL STARZL at trustoria.com
Thomas E Starzl Photo 1
Dr. Thomas E Starzl, Pittsburgh PA - MD (Doctor of Medicine)

Dr. Thomas E Starzl, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
General Surgery, Thoracic Surgery
Address:
1084 Scaife Hall, Pittsburgh 15261
MUH 933-W
3459 5Th Ave, Pittsburgh 15213
(412) 692-4888 (Phone), (412) 692-4892 (Fax)
Certifications:
General Surgery, 1958, Thoracic Surgery, 1959
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1952
The Johns Hopkins Hospital
Jackson Meml Hosp


Thomas Starzl Photo 2
Surgeon At Upmc Health Plan

Surgeon At Upmc Health Plan

Position:
Surgeon at UPMC Health Plan
Location:
Greater Pittsburgh Area
Industry:
Insurance
Work:
UPMC Health Plan - Surgeon


Thomas Starzl Photo 3
Method Of Regulating Dendritic Cell Maturation

Method Of Regulating Dendritic Cell Maturation

US Patent:
5871728, Feb 16, 1999
Filed:
Mar 31, 1995
Appl. No.:
8/414461
Inventors:
Angus W. Thomson - Pittsburgh PA
Anthony J. Demetris - Glenshaw PA
Thomas E. Starzl - Pittsburgh PA
Assignee:
University of Pittsburgh - Pittsburgh PA
International Classification:
C12N 508
US Classification:
424 937
Abstract:
A novel transplantation method for enhancing tolerogenicity in a host mammal to a transplant graft specimen from a donor mammal is disclosed. According to this method, immature mammalian dendritic cells propagated in the presence of a cytokine are administered to the host mammal in advance of transplantation. Tolerogenicity is enhanced in the host mammal when the immature mammalian dendritic cells concentrate in T-dependent regions of secondary lymphoid tissue of the host mammal, where the expression of major histocompatibility complex class II antigen by the immature mammalian dendritic cells is upregulated. Also disclosed is a novel method of effecting the maturation of immature dendritic cells in the presence of a cytokine and an extracellular matrix protein. These mature mammalian dendritic cells, which upregulate the expression of major histocompatibility complex class II antigen, can then be used to enhance the immune response of a host mammal.


Thomas Starzl Photo 4
Mammalian Augmenter Of Liver Regeneration And Variants Thereof

Mammalian Augmenter Of Liver Regeneration And Variants Thereof

US Patent:
5811397, Sep 22, 1998
Filed:
Jun 12, 1996
Appl. No.:
8/665484
Inventors:
Antonio T. Francavilla - Pittsburgh PA
Michio Hagiya - Shiga, JP
Thomas E. Starzl - Pittsburgh PA
Assignee:
University of Pittsburgh - Pittsburgh PA
Toyobo Co.,Ltd.
International Classification:
A61K 3818, C07K 14475
US Classification:
514 12
Abstract:
Full-length cDNA clones have been isolated encoding purified augmenter of liver regeneration (ALR) polypeptides prepared from the cytosol of livers from weanling rats and from humans. The full-length clone from the rat is a 1226 bp cDNA containing an 81 bp 5'-untranslated region, a 594 bp coding region and a 551 bp 3'-untranslated region. The coding region encodes three proteins with estimated molecular weights of 15,081, 20,193 and 22,835. The full-length clone from the human consists of a 727 bp cDNA containing a 4 bp 5'-untranslated region, a 615 bp coding region and a 108 bp 3'-untranslated region, including the termination codon TAG and the poly (A) region. The 615 bp coding region encodes four proteins, human ALR-V1, ALR-V2, ALR-V3 and ALR, having estimated molecular weights of 23,448, 20,834, 20,703 and 15,028, respectively.


Thomas Starzl Photo 5
Composition Containing Immature Mammalian Dendritic Cells For Enhancing Tolerogenicity To Foreign Graft

Composition Containing Immature Mammalian Dendritic Cells For Enhancing Tolerogenicity To Foreign Graft

US Patent:
6224859, May 1, 2001
Filed:
Apr 23, 1998
Appl. No.:
9/064829
Inventors:
Angus W. Thomson - Pittsburgh PA
Anthony J. Demetris - Glenshaw PA
Thomas E. Starzl - Pittsburgh PA
Assignee:
The University of Pittsburgh - Pittsburgh PA
International Classification:
A01N 6300, C12N 502, C12N 508
US Classification:
424 937
Abstract:
A novel transplantation method for enhancing tolerogenicity in a host mammal to a transplant graft specimen from a donor mammal is disclosed. According to this method, immature mammalian dendritic cells propagated in the presence of a cytokine are administered to the host mammal in advance of transplantation. Tolerogenicity is enhanced in the host mammal when the immature mammalian dendritic cells concentrate in T-dependent regions of secondary lymphoid tissue of the host mammal, where the expression of major histocompatibility complex class II antigen by the immature mammalian dendritic cells is upregulated. Also disclosed is a novel method of effecting the maturation of immature dendritic cells in the presence of a cytokine and an extracellular matrix protein. These mature mammalian dendritic cells, which upregulate the expression of major histocompatibility complex class II antigen, can then be used to enhance the immune response of a host mammal.


Thomas Starzl Photo 6
Mammalian Augmenter Of Liver Regeneration And Variants Thereof

Mammalian Augmenter Of Liver Regeneration And Variants Thereof

US Patent:
5607844, Mar 4, 1997
Filed:
Jan 3, 1995
Appl. No.:
8/367968
Inventors:
Antonio T. Francavilla - Pittsburgh PA
Michio Hagiya - Shiga, JP
Thomas E. Starzl - Pittsburgh PA
Assignee:
University of Pittsburgh - Pittsburgh PA
International Classification:
C12N 121, C12N 1512, C12N 1563, C12P 2100
US Classification:
435 691
Abstract:
Full-length cDNA clones have been isolated encoding purified augmenter of liver regeneration (ALR) polypeptides prepared from the cytosol of livers from weanling rats and from humans. The full-length clone from the rat is a 1226 bp cDNA containing an 81 bp 5'-untranslated region, a 594 bp coding region and a 551 bp 3'-untranslated region. The coding region encodes three proteins with estimated molecular weights of 15,081, 20,193 and 22,835. The full-length clone from the human consists of a 727 bp cDNA containing a 4 bp 5'-untranslated region, a 615 bp coding region and a 108 bp 3'-untranslated region, including the termination codon TAG and the poly (A) region. The 615 bp coding region encodes four proteins, human ALR-V1, ALR-V2, ALR-V3 and ALR, having estimated molecular weights of 23,448, 20,834, 20,703 and 15,028, respectively.


Thomas Starzl Photo 7
Augmenter Of Liver Regeneration (Alr)

Augmenter Of Liver Regeneration (Alr)

US Patent:
5480797, Jan 2, 1996
Filed:
Feb 16, 1994
Appl. No.:
8/197496
Inventors:
Antonio T. Francavilla - Pittsburgh PA
Michio Hagiya - Shiga, JP
Thomas E. Starzl - Pittsburgh PA
Assignee:
Toyobo Co., Ltd. - Osaka
University of Pittsburgh - Pittsburgh PA
International Classification:
C12N 121, C12N 510, C12N 1512, C12N 1563
US Classification:
4352402
Abstract:
A full-length cDNA clone has been isolated encoding a purified augmenter of liver regeneration (ALR) polypeptide prepared from the cytosol of livers from weanling rats. The 1. 2 kb cDNA includes a 299 bp 5'-untranslated region, a 375 bp coding region and a 551 bp 3'-untranslated region. The cDNA encodes a protein consisting of 125 amino acids. The molecular weight of ALR calculated from the cDNA was 15,081 which is consistent with the size estimated by SDS-PAGE under reducing conditions. The molecular weight of the purified native ALR estimated by SDS-PAGE under non-reducing conditions is about 30,000, apparently with a homodimer structure. The recombinant ALR produced by expression of the cDNA in cultured cells was tested in vivo in the canine Eck's fistula model and found to have a potency equivalent to the purified native ALR. The most obvious immediate clinical use for the augmenter of liver regeneration is in the treatment of hepatic failure.


Thomas Starzl Photo 8
Mammalian Augmenter Of Liver Regeneration (Alr): Human And Rat

Mammalian Augmenter Of Liver Regeneration (Alr): Human And Rat

US Patent:
5550037, Aug 27, 1996
Filed:
Jul 15, 1994
Appl. No.:
8/275370
Inventors:
Antonio T. Francavilla - Pittsburgh PA
Michio Hagiya - Shiga, JP
Thomas E. Starzl - Pittsburgh PA
Assignee:
University of Pittsburgh - Pittsburgh PA
Toyobo Co. Ltd. - Osaka
International Classification:
C12N 121, C12N 510, C12N 1512, C12N 1563
US Classification:
435 691
Abstract:
Full-length cDNA clones have been isolated encoding purified augmenter of liver regeneration (ALR) polypeptides prepared from the cytosol of livers from human and from weanling rats. The 0. 5 kb human ALR cDNA includes a 33 bp 5'-untranslated region, a 375 bp coding region and a 107 bp 3'-untranslated region. The cDNA encodes a protein consisting of 125 amino acids. The molecular weight of human ALR calculated from the cDNA was 15,028. A comparison of the sequences for the human ALR with those of the rat ALR shows 71% homology at the nucleotide level and 86% homology at the amino acid level. The most obvious immediate clinical use for the augmenter of liver regeneration is in the treatment of hepatic failure.


Thomas Starzl Photo 9
Method For Treating Hepatic Diseases And Regenerating Liver Tissue Using Fk 506 And Related Compounds

Method For Treating Hepatic Diseases And Regenerating Liver Tissue Using Fk 506 And Related Compounds

US Patent:
5196437, Mar 23, 1993
Filed:
Dec 18, 1990
Appl. No.:
7/629028
Inventors:
Thomas E. Starzl - Pittsburgh PA
Satoru Todo - Pittsburgh PA
Antonio Francavilla - Pittsburgh PA
Assignee:
Fujisawa Pharmaceutical Company, Ltd. - Osaka
International Classification:
A61K 3144, A61K 3140
US Classification:
514294
Abstract:
Macrolide compounds having the structure shown below ##STR1## wherein R. sup. 1 is hydroxy or protected hydroxy, R. sup. 2 is hydrogen, hydroxy or protected hydroxy, R. sup. 3 is methyl, ethyl, propyl or allyl, R. sup. 4 is hydroxy, methoxy or oxo, n is 1 or 2 and the symbol of a line and a dotted is a single bond or a double bond, provided that R. sup. 2 is not protected hydroxy where R. sup. 4 is hydroxy or oxo are used to treat hepatic disease and regenerate liver tissue by facilitating hypertrophy and hyperplasia of hepatocytes.


Thomas Starzl Photo 10
Method For Treating Pyoderma And Sezary's Syndrome Using Fk 506 And Related Compounds

Method For Treating Pyoderma And Sezary's Syndrome Using Fk 506 And Related Compounds

US Patent:
5348966, Sep 20, 1994
Filed:
Nov 22, 1993
Appl. No.:
8/155533
Inventors:
Thomas E. Starzl - Pittsburgh PA
Satoru Todo - Pittsburgh PA
Assignee:
Fujisawa Pharmaceutical Co., Ltd. - Osaka
International Classification:
A61K 31445, A61K 3133, A61K 3140
US Classification:
514326
Abstract:
Administration of FK506 or related macrolide compounds is effective for the treatment of pyoderma and Sezary's syndrome.